These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
614 related articles for article (PubMed ID: 26198048)
21. High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma. Liu Y; Yang L; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J Sci Rep; 2015 Nov; 5():16954. PubMed ID: 26599282 [TBL] [Abstract][Full Text] [Related]
22. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome. Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922 [TBL] [Abstract][Full Text] [Related]
23. RALY RNA binding protein-like reduced expression is associated with poor prognosis in clear cell renal cell carcinoma. Cui ZW; Xia Y; Ye YW; Jiang ZM; Wang YD; Wu JT; Sun L; Zhao J; Fa PP; Sun XJ; Gui YT; Cai ZM Asian Pac J Cancer Prev; 2012; 13(7):3403-8. PubMed ID: 22994768 [TBL] [Abstract][Full Text] [Related]
24. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma. Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688 [TBL] [Abstract][Full Text] [Related]
25. Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma. An H; Zhu Y; Xie H; Liu Y; Liu W; Fu Q; Ye D; Xu J Tumour Biol; 2016 Apr; 37(4):4523-9. PubMed ID: 26503211 [TBL] [Abstract][Full Text] [Related]
26. Galectin-8 predicts postoperative recurrence of patients with localized T1 clear cell renal cell carcinoma. Liu Y; Xu L; Zhu Y; Zhang W; Liu W; Liu H; Xu J Urol Oncol; 2015 Mar; 33(3):112.e1-8. PubMed ID: 25499921 [TBL] [Abstract][Full Text] [Related]
27. Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma. Fu H; Liu Y; Xu L; Liu W; Fu Q; Liu H; Zhang W; Xu J Tumour Biol; 2015 Aug; 36(8):5791-9. PubMed ID: 25716202 [TBL] [Abstract][Full Text] [Related]
28. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis. Cui Y; Zhou Z; Chai Y; Zhang Y J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313 [TBL] [Abstract][Full Text] [Related]
29. DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC). Evelönn EA; Degerman S; Köhn L; Landfors M; Ljungberg B; Roos G Tumour Biol; 2016 Aug; 37(8):10219-28. PubMed ID: 26831665 [TBL] [Abstract][Full Text] [Related]
30. Expression of Neural Wiskott-Aldrich Syndrome Protein in Clear Cell Renal Cell Carcinoma and Its Correlation with Clinicopathological Features. Liu GH; Chen J; Ji ZG; Zhou L Urol Int; 2015; 95(1):79-85. PubMed ID: 25115631 [TBL] [Abstract][Full Text] [Related]
31. Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241 [TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of p21-activated kinase 6 expression in patients with clear cell renal cell carcinoma. Liu W; Liu H; Liu Y; Xu L; Zhang W; Zhu Y; Xu J; Gu J Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S575-83. PubMed ID: 24715215 [TBL] [Abstract][Full Text] [Related]
34. A cluster of metabolism-related genes predict prognosis and progression of clear cell renal cell carcinoma. Liu M; Pan Q; Xiao R; Yu Y; Lu W; Wang L Sci Rep; 2020 Jul; 10(1):12949. PubMed ID: 32737333 [TBL] [Abstract][Full Text] [Related]
35. Increased expression of MUC3A is associated with poor prognosis in localized clear-cell renal cell carcinoma. Niu T; Liu Y; Zhang Y; Fu Q; Liu Z; Wang Z; Fu H; Xu J; Liu K Oncotarget; 2016 Aug; 7(31):50017-50026. PubMed ID: 27374181 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value of CXCR4 expression in patients with clear cell renal cell carcinoma. Li G; Badin G; Zhao A; Gentil-Perret A; Tostain J; Péoc'h M; Gigante M Histol Histopathol; 2013 Sep; 28(9):1217-22. PubMed ID: 23609324 [TBL] [Abstract][Full Text] [Related]
37. Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival. Belsante M; Darwish O; Youssef R; Bagrodia A; Kapur P; Sagalowsky AI; Lotan Y; Margulis V Urol Oncol; 2014 Jan; 32(1):30.e23-8. PubMed ID: 23428539 [TBL] [Abstract][Full Text] [Related]
38. High expression of chemokine CCL2 is associated with recurrence after surgery in clear-cell renal cell carcinoma. Yang Y; Zhai C; Chang Y; Zhou L; Shi T; Tan C; Xu L; Xu J Urol Oncol; 2016 May; 34(5):238.e19-26. PubMed ID: 26749463 [TBL] [Abstract][Full Text] [Related]
39. NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer. Wu J; Wan F; Sheng H; Shi G; Shen Y; Lin G; Dai B; Zhu Y; Ye D J Cancer; 2017; 8(5):852-860. PubMed ID: 28382148 [TBL] [Abstract][Full Text] [Related]
40. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma. Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]